Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1987-08-31
1989-12-26
Sutto, Anton H.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
544278, 544255, 549 28, C07D49504, A61K 31505
Patent
active
048898562
ABSTRACT:
7,8-Dihydro-4-(1-piperazinyl)-6H-thiopyranopyrimidines have .beta.-adrenergic blocking properties and are thus useful in the treatment of cardiovascular ailments known to be amenable to .beta.-blocker therapy. Certain of the compounds are useful in the treatment of elevated intraocular pressure by topical ocular administration.
REFERENCES:
patent: 3272811 (1966-09-01), Ohnacker et al.
patent: 3316257 (1967-04-01), Ohnacker
patent: 3318881 (1967-05-01), Ohnacker et al.
patent: 3318883 (1967-05-01), Ohnacker et al.
patent: 4435566 (1984-03-01), Ohno et al.
Ohno et al. .sup.II Chem Pharm. Bull. 34 pp. 4150-4165 (10/1986).
Ono et al. Chemical Abstract vol. 106, No. 33096w for JP61/180788 (8/13/86).
Baldwin John J.
Pietruszkiewicz Adolph
Tolman Richard L.
Wagner Arthur F.
Bernhardt E.
DiPrima Joseph F.
Merck & Co. , Inc.
Nicholson William H.
Sutto Anton H.
LandOfFree
7,8-dihydro-4-(1-pierazinyl)-6H-thiopyrano-[3,2-d] pyrimidines a does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 7,8-dihydro-4-(1-pierazinyl)-6H-thiopyrano-[3,2-d] pyrimidines a, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 7,8-dihydro-4-(1-pierazinyl)-6H-thiopyrano-[3,2-d] pyrimidines a will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1577406